Navigation Links
City of Hope researchers to present rectal cancer, palliative care, benchmarking studies at ASCO
Date:6/5/2011

DUARTE, Calif. -- City of Hope researchers participated in more than 50 studies on improvements to cancer treatment, patient care and clinical trials to be presented at the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, running from June 3 through 7.

Research highlights include:

"Impact of neoadjuvant chemotherapy following chemoradiation on tumor response, adverse events and surgical complications in patients with advanced renal cancer treated with TME."
Abstract# 3514
Monday, June 6, 8 a.m. to 12 p.m.
McCormick Place E450b
Discussion: 11:30 a.m. to 12:30 p.m., McCormick Place Hall D1

Study reveals rectal cancer patients benefit from having additional chemotherapy prior to surgery. Total mesorectal excision, in which a large portion of the bowel is removed, is considered the gold standard treatment for rectal cancers. Prior to surgery, patients often undergo neoadjuvant therapy with combined chemotherapeutic and radiation treatments. Patients who achieve a pathologic complete response to the neoadjuvant therapy have better expected outcomes from surgery, but a majority of patients do not show complete response, which prompts physicians to proscribe additional chemotherapy after surgery. Julio Garcia-Aguilar, M.D., Ph.D., chair of City of Hope's Department of Surgery, is the lead author of the multicenter study that examined how increasing cycles of chemotherapy in addition to chemoradiation prior to the surgery would impact a patient's complete response, treatment side effects and possible complications from surgery.

Three sequential phase II clinical trials enrolled a total of 175 patients with either stage II or III rectal cancer. The patients were treated with neoadjuvant chemoradiation, and then received different specified cycles of neoadjuvant chemotherapy, followed by total mesorectal excision.

"Patients who receive additional chemotherapy before their surgical procedures may achieve a greater rate of pathologic complete response without increases in side effects or complications compared to the standard approach, which can lead to better outcomes and no need for additional chemotherapy after surgery," said Garcia-Aguilar. "We're currently investigating whether providing all adjuvant chemotherapy before surgery rather than after may be an improved approach to treatment."

"Palliative care for patients with advanced lung cancer."
Abstract# e19610
J Clin Oncol 29: 2011 (suppl; abstr e19610)

Patients have unmet needs and gaps in care when palliative medicine is not an integrated part of their treatment plan. Palliative care focuses on addressing physical, psychological, emotional and spiritual issues that patients face as they undergo treatment for their diagnosis. Marianna Koczywas, M.D., assistant professor in City of Hope's Department of Medical Oncology & Therapeutics Research, is the lead author of a National Institutes of Health study that examined lung cancer patients' experience of treatment with and without integrated palliative care. Patients with late-stage lung cancer were followed for six months and were assessed on four dimensions of quality of life. Eighty patients were enrolled in the group that received usual care without integrated palliative care. The key unaddressed symptoms patients reported were lack of energy, difficulty in sleeping, worrying and pain. Chart audits of the patients revealed limited use of advance directives or palliative care consultations.

"There is a significant gap in supportive care for lung cancer patients where we can provide better care for the issues that patients face alongside their cancer," said Koczywas. "These findings help us in developing a comprehensive educational intervention and resources to meet the needs of our patients."

"Benchmarking oncology clinical trials metrics across AACI member centers."
Abstract# e16613
J Clin Oncol 29: 2011 (suppl; abstr e16613)

Douglas C. Stahl, Ph.D., vice president of Clinical Research Operations, is the lead author on a benchmarking study that was conducted as part of the Association of American Cancer Institutes (AACI) Clinical Research Initiative. The study was designed to document the time required for various clinical trial review and approval processes, capture best practices, and identify common challenges among participating centers. The research team reviewed 1,161 clinical trials reviewed at 14 different cancer centers during a one year period. Results showed a high degree of variability among participating centers, with contract negotiation requiring the greatest amount of time compared to all other review and approval processes. The study also revealed widespread challenges associated with incomplete and inconsistent capture of timing metrics for key process milestones.

"Opening an oncology clinical trial is a complex, time consuming process that is highly variable and inconsistently documented," said Stahl. "Our research has identified opportunities for process standardization and improvement that can be collaboratively developed and disseminated throughout the AACI."


'/>"/>

Contact: Shawn Le
sle@coh.org
800-888-5323
City of Hope
Source:Eurekalert

Related medicine news :

1. U of Alberta researchers hoping to stop heart disease in cancer patients before it starts
2. U of A researchers hope to stop heart
3. UofL researchers uncover mechanism in saliva production
4. UF researchers suggest cholera vaccination strategies for Zimbabwe
5. Researchers characterize epigenetic fingerprint of 1,628 people
6. Researchers develop strategy to improve patient adherence
7. NIH-funded researchers find new ways to confuse blood-seeking mosquitoes
8. GW researchers show host Mta1 gene is required for optimal survival of schistosome parasites, a leading global cause of cancer
9. Researchers map, measure brains neural connections
10. Carnegie Mellon researchers uncover how the brain processes faces
11. UCI researchers find link between environment and genetics in triggering MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy Eyeglasses, an ... United States and Canada wear eyeglasses. Once considered to be a purely functional part ... fashion statement. Even celebrities use glasses as a way of creating an iconic image—like ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women ... diagnosed with endometriosis. These women need a treatment plan to not only alleviate ... that can help for preservation of fertility and ultimately achieving a pregnancy. The ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... Market Analysis 2016 - Forecast to 2022" report to ... report contains up to date financial data derived from varied ... major trends with potential impact on the market during the ... segmentation which comprises of sub markets, regional and country level ...
Breaking Medicine Technology: